Search

everythinglearnresearchcommunity

for

Search:↓

N-acetylcysteine may prevent hair loss caused by chemotherapy.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Itraconazole effectively treats scalp fungus, with continuous use more effective than pulse therapy.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

Tangent screens help detect visual field defects from vigabatrin.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Cryotherapy and compression therapy might help prevent chemotherapy nerve damage, but more research is needed.